2 options
Prescription pain medications : frequently asked questions and answers for health care professionals, and law enforcement personnel / supported by Drug Enforcement Administration, Last Acts Partnership, Pain & Policy Studies Group, University of Wisconsin.
- Format:
- Book
- Government document
- Language:
- English
- Subjects (All):
- Pain--Treatment--United States.
- Pain.
- Palliative treatment--United States.
- Palliative treatment.
- Analgesics--United States.
- Analgesics.
- Drug abuse--United States--Prevention.
- Drug abuse.
- Medication abuse--United States--Prevention.
- Medication abuse.
- Drug control--United States.
- Drug control.
- Pain--drug therapy.
- Palliative Care--legislation & jurisprudence.
- Drug Prescriptions--standards.
- Drug and Narcotic Control.
- Substance-Related Disorders--prevention & control.
- Public Policy.
- Analgesics, Opioid--therapeutic use.
- United States.
- Drug abuse--Prevention.
- Medication abuse--Prevention.
- Pain--Treatment.
- Medical Subjects:
- Pain--drug therapy.
- Palliative Care--legislation & jurisprudence.
- Drug Prescriptions--standards.
- Drug and Narcotic Control.
- Substance-Related Disorders--prevention & control.
- Public Policy.
- Analgesics, Opioid--therapeutic use.
- United States.
- Physical Description:
- 1 online resource
- Place of Publication:
- [Washington, D.C.] : [U.S. Dept. of Justice Drug Enforcement Administration Diversion Control Program], [2004]
- Notes:
- Publication information from web site.
- "In August 2004, the Drug Enforcement Administration (DEA) published on its Office of Diversion Control Web site a document entitled "Prescription pain medications: frequently asked questions and answers for health care professionals and law enforcement personnel." The document contained misstatements and has therefore been removed from the DEA Web site. DEA wishes to emphasize that the document was not approved as an official statement of the agency and did not and does not have the force and effect of law. DEA recognizes that the proper use of controlled substances in the treatment of pain remains an extremely important issue. Accordingly, DEA intends to address this matter in the future."
- Includes bibliographical references.
- Title from title screen (description based on contents viewed Oct. 23, 2004).
- OCLC:
- 56142012
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.